Clinical Trial Update: Six Month Clinical Research Study for Patients With Moderate or Severe Dry Eye Syndrome [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for moderate to severe dry eye syndrome, sponsored by Allergan, involving patients with Keratoconjunctivitis Sicca and related aut…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Keratoconjunctivitis Sicca
• Rheumatoid Arthritis
• Sjögren Syndrome
• Systemic Lupus Erythematosus
• Systemic Sclerosis

Snippet

Sponsor: Allergan | Conditions: Keratoconjunctivitis Sicca, Sjogren's Syndrome | Phase 3 | Status: COMPLETED